Cargando…

Target RNA-guided protease activity in type III-E CRISPR–Cas system

The type III-E CRISPR–Cas systems are newly identified adaptive immune systems in prokaryotes that use a single Cas7–11 protein to specifically cleave target RNA. Cas7–11 could associate with Csx29, a putative caspase-like protein encoded by the gene frequently found in the type III-E loci, suggesti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Xiaoshen, Yu, Guimei, Wen, Yanan, An, Qiyin, Li, Xuzichao, Liao, Fumeng, Lian, Chengwei, Zhang, Kai, Yin, Hang, Wei, Yong, Deng, Zengqin, Zhang, Heng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Molecular Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9825189/ https://www.ncbi.nlm.nih.gov/pubmed/36484100 http://dx.doi.org/10.1093/nar/gkac1151

Ejemplares similares

Inhibitory mechanism of CRISPR-Cas9 by AcrIIC4
por: Li, Xuzichao, et al.
Publicado: (2023)

Structural insights into mechanisms of Argonaute protein-associated NADase activation in bacterial immunity
por: Wang, Xiaoshen, et al.
Publicado: (2023)

Inhibition mechanisms of CRISPR-Cas9 by AcrIIA17 and AcrIIA18
por: Wang, Xiaoshen, et al.
Publicado: (2021)

Unique properties of spacer acquisition by the type III-A CRISPR-Cas system
por: Zhang, Xinfu, et al.
Publicado: (2021)

Improving CRISPR–Cas specificity with chemical modifications in single-guide RNAs
por: Ryan, Daniel E, et al.
Publicado: (2018)

Spacer acquisition by Type III CRISPR–Cas system during bacteriophage infection of Thermus thermophilus
por: Artamonova, Daria, et al.
Publicado: (2020)

Structural and functional characterization of Cas2 of CRISPR-Cas subtype I-C lacking the CRISPR component
por: Anand, Vineet, et al.
Publicado: (2022)

Regulation of the RNA and DNA nuclease activities required for Pyrococcus furiosus Type III-B CRISPR–Cas immunity
por: Foster, Kawanda, et al.
Publicado: (2020)

Substrate Generation for Endonucleases of CRISPR/Cas Systems
por: Zoephel, Judith, et al.
Publicado: (2012)

An archaeal virus-encoded anti-CRISPR protein inhibits type III-B immunity by inhibiting Cas RNP complex turnover
por: Liu, Jilin, et al.
Publicado: (2023)

The impact of nucleosome structure on CRISPR/Cas9 fidelity
por: Handelmann, Christopher R, et al.
Publicado: (2023)

Spacer acquisition from RNA mediated by a natural reverse transcriptase-Cas1 fusion protein associated with a type III-D CRISPR–Cas system in Vibrio vulnificus
por: González-Delgado, Alejandro, et al.
Publicado: (2019)

Cas4–Cas1 fusions drive efficient PAM selection and control CRISPR adaptation
por: Almendros, Cristóbal, et al.
Publicado: (2019)

A Small RNA Is Linking CRISPR–Cas and Zinc Transport
por: Märkle, Pascal, et al.
Publicado: (2021)

Hydrazone chemistry-mediated CRISPR/Cas12a system for bacterial analysis
por: Sheng, Anzhi, et al.
Publicado: (2022)

Anti-CRISPR AcrIF9 functions by inducing the CRISPR–Cas complex to bind DNA non-specifically
por: Lu, Wang-Ting, et al.
Publicado: (2021)

Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system
por: Bikard, David, et al.
Publicado: (2013)

CRISPR repeat sequences and relative spacing specify DNA integration by Pyrococcus furiosus Cas1 and Cas2
por: Grainy, Julie, et al.
Publicado: (2019)

The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli
por: Sapranauskas, Rimantas, et al.
Publicado: (2011)

CRISPR/Cas9-induced structural variations expand in T lymphocytes in vivo
por: Wu, Jinchun, et al.
Publicado: (2022)

A Blue Light-Inducible CRISPR-Cas9 System for Inhibiting Progression of Melanoma Cells
por: Wu, Xia, et al.
Publicado: (2020)

The Cas6e ribonuclease is not required for interference and adaptation by the E. coli type I-E CRISPR-Cas system
por: Semenova, Ekaterina, et al.
Publicado: (2015)

Advances in the application of CRISPR-Cas technology in rapid detection of pathogen nucleic acid
por: Li, Xiaoping, et al.
Publicado: (2023)

Transcriptional Inhibition of lncRNA gadd7 by CRISPR/dCas9-KRAB Protects Spermatocyte Viability
por: Zhao, Jun, et al.
Publicado: (2021)

The efficient generation of knockout microglia cells using a dual-sgRNA strategy by CRISPR/Cas9
por: Zhang, Mengfei, et al.
Publicado: (2022)

CRISPR DNA elements controlling site-specific spacer integration and proper repeat length by a Type II CRISPR–Cas system
por: Kim, Jenny G, et al.
Publicado: (2019)

CRISPR-CasRx Targeting LncRNA LINC00341 Inhibits Tumor Cell Growth in vitro and in vivo
por: Li, Chunjing, et al.
Publicado: (2021)

Cryo-EM structures of African swine fever virus topoisomerase
por: Zhao, Yan, et al.
Publicado: (2023)

Detection and characterization of spacer integration intermediates in type I-E CRISPR–Cas system
por: Arslan, Zihni, et al.
Publicado: (2014)

The Influence of Copy-Number of Targeted Extrachromosomal Genetic Elements on the Outcome of CRISPR-Cas Defense
por: Severinov, Konstantin, et al.
Publicado: (2016)

Bio-Layer Interferometry Analysis of the Target Binding Activity of CRISPR-Cas Effector Complexes
por: Müller-Esparza, Hanna, et al.
Publicado: (2020)

Spontaneous Embedding of DNA Mismatches Within the RNA:DNA Hybrid of CRISPR-Cas9
por: Mitchell, Brandon P., et al.
Publicado: (2020)

Type IV CRISPR–Cas systems are highly diverse and involved in competition between plasmids
por: Pinilla-Redondo, Rafael, et al.
Publicado: (2020)

Knockdown of Long Non-coding RNA SNGH3 by CRISPR-dCas9 Inhibits the Progression of Bladder Cancer
por: Cao, Yu, et al.
Publicado: (2021)

CRISPR Cas13-Based Tools to Track and Manipulate Endogenous Telomeric Repeat-Containing RNAs in Live Cells
por: Xu, Meng, et al.
Publicado: (2022)

Selective disruption of an oncogenic mutant allele by CRISPR/Cas9 induces efficient tumor regression
por: Koo, Taeyoung, et al.
Publicado: (2017)

Spacer-length DNA intermediates are associated with Cas1 in cells undergoing primed CRISPR adaptation
por: Musharova, Olga, et al.
Publicado: (2017)

The action of Escherichia coli CRISPR–Cas system on lytic bacteriophages with different lifestyles and development strategies
por: Strotskaya, Alexandra, et al.
Publicado: (2017)

Downregulation of CacyBP by CRISPR/dCas9-KRAB Prevents Bladder Cancer Progression
por: Zheng, Hanxiong, et al.
Publicado: (2021)

From DNA-protein interactions to the genetic circuit design using CRISPR-dCas systems
por: Shaytan, A. K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2sp1j6a58bk55f3t8r1oqblu07